▷ Grifols Dividends 【Calendar 2026】

Upcoming Grifols dividend

Change(%)

-58.83%

Decrease

Next payment 0.15€

Next payment date Aug 13, 2025

Last payment 0.364348€

Last payment date Jun 7, 2021

00 D 00 H 00 M 00 S

Ex-Dividend: 8/11/25

Confirmed

When are the upcoming Grifols dividends in 2026?

▶

Holders of Grifols (GRF) can expect to receive 0,15 euros per share in dividends on August 13, 2025, yielding 1.66%.

What is the last day to buy Grifols stocks and get dividends?

▶

The Last Trading Day (August 8, 2025) marks your last chance to qualify for dividends.

Last Grifols dividend

▶

Grifols paid a dividend of 0.364348 euros on June 7, 2021, corresponding to a yield of 1.68%.

Dividend policy of Grifols

▶

Grifols has opted for a low dividend policy over the years. Always with a dividend yield of less than 2%.

In recent years they have divided the fiscal years into two payment dates, one at the end of the year of the fiscal year in question, and the other in the middle of the following year.

They are currently having problems distributing part of the profits to shareholders due to the company's large debt.

Payout Ratio Grifols Dividends

Grifols paid 2% of its net income in the last fiscal period as dividends.

Grifols's earnings (7,438,000,128.00€) are sufficient to cover the dividend payment. This payment represents 2% of the total net profit of GRF.

Dividend payout ratio Payout Ratio

Dividend calendar of Grifols

These are the most important events of the Grifols calendar in 2026:

Event	Day
Last trading date	August 8, 2025
Ex-Dividend (Ex-Date)	August 11, 2025
Record date	August 12, 2025
Date of payment	August 13, 2025

Data confirmed by the company Grifols (GRF).

Confirmed Source

Historical annual dividend yields of Grifols

Over the past 5 years, Grifols has not consistently distributed dividends.

Increasing Dividends Dividend yield

Dividend yield of Grifols vs. the sector

Grifols's dividend yield (0.91%) is below the sector average (1.86%).

Comparison with industry average

Grifols's dividend yield is below the top 75% (1.44%) of the sector.

Evaluation with respect to competence.

Dividend yield history in Grifols

Over the past 5 years, Grifols has not consistently distributed dividends.

Dividend stability

Dividend history of Grifols

In this table you can see the complete history:

Year	Ex-Dividend	Amount	Total
2021	06/03/2021	0.364348 €	0.364348 €
2020	10/26/2020	0.1616 €	0.1616 €
2019	12/02/2019 06/07/2019	0.2 € 0.145142 €	0.345142 €
2018	11/30/2018 06/01/2018	0.2 € 0.203996 €	0.403996 €
2017	12/01/2017 05/30/2017	0.18 € 0.135615 €	0.315615 €
2016	12/05/2016 06/02/2016	0.18 € 0.132572 €	0.312572 €
2015	12/10/2015 06/08/2015	0.175 € 0.147545 €	0.322545 €
2014	12/04/2014 06/05/2014	0.125722 € 0.100342 €	0.226064 €
2013	06/05/2013	0.1 €	0.1 €
2010	07/01/2010	0.063946 €	0.063946 €
2009	12/18/2009 06/02/2009	0.076528 € 0.116048 €	0.192576 €
2008	06/23/2008	0.071935 €	0.071935 €
2007	07/02/2007	0.030171 €	0.030171 €

Grifols dividend capture strategy

Step 1: Buy Grifols shares (GRF) one day before ex-dividend date

Date of purchase Aug 8, 2025

Next ex-dividend date Aug 11, 2025

Step 2: Sell Grifols shares (GRF) when the price recovers.

Date of sale (estimated) N/A

Average price recovery N/A

Average return on cost N/A

The dividend capture strategy is based on historical Grifols data. Past performance is no guarantee of future results.

Information about Grifols

Full name Grifols, S.A.

Ticker GRF

Sector Health Care

Industry Drug Manufacturers - General

Market Capitalization 6.14B €

Number of Employees 23,833

Description of the company

Grifols is a Spanish biotechnology and pharmaceutical company. It was founded in 1940 and is headquartered in Barcelona, Spain. It is listed on the Spanish stock exchange and is part of the IBEX 35 index.

It is principally engaged in the research, development, production and marketing of therapeutic products derived from blood plasma. These products include coagulation factors, albumin, antibodies and alpha-1 protease inhibitor.

The company has won several awards for its commitment to quality and safety. It is currently active in Europe, North America, Latin America, Asia and Africa and is one of the world's leading manufacturers of plasma-based products. In addition, it has a network of more than 30,000 plasma donors worldwide.